Abstract | OBJECTIVES: BACKGROUND: METHODS: Data from the American Heart Association's Get with the Guidelines- Coronary Artery Disease national database were analyzed for 81,570 post-AMI patients from 219 hospitals between 2006 and 2009, of whom 11,255 (13.8%) were eligible for aldosterone antagonist therapy. RESULTS: CONCLUSIONS: Although rates of aldosterone antagonist use are increasing slightly over time, the vast majority of AMI patients eligible for treatment fail to receive it at hospital discharge. The reason for this discrepancy between guideline-based therapy and actual prescribing patterns is unclear and should be further studied.
|
Authors | Andrew N Rassi, Matthew A Cavender, Gregg C Fonarow, Christopher P Cannon, Adrian F Hernandez, Eric D Peterson, W Frank Peacock, Warren K Laskey, Sylvia E Rosas, Xin Zhao, Lee H Schwamm, Deepak L Bhatt |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 61
Issue 1
Pg. 35-40
(Jan 08 2013)
ISSN: 1558-3597 [Electronic] United States |
PMID | 23137936
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Mineralocorticoid Receptor Antagonists
|
Topics |
- Aged
- Diabetes Mellitus
(epidemiology)
- Drug Prescriptions
(statistics & numerical data)
- Drug Utilization
(statistics & numerical data, trends)
- Female
- Guideline Adherence
(statistics & numerical data)
- Heart Failure
(epidemiology)
- Hospital Bed Capacity
- Humans
- Kidney Diseases
(epidemiology)
- Male
- Mineralocorticoid Receptor Antagonists
(therapeutic use)
- Multivariate Analysis
- Myocardial Infarction
(drug therapy, epidemiology)
- Myocardial Revascularization
- Patient Discharge
- Practice Guidelines as Topic
- Registries
- Smoking
(epidemiology)
- Stroke Volume
- United States
(epidemiology)
|